000 | 01086 a2200313 4500 | ||
---|---|---|---|
005 | 20250515054655.0 | ||
264 | 0 | _c20070330 | |
008 | 200703s 0 0 eng d | ||
022 | _a1873-4286 | ||
024 | 7 |
_a10.2174/138161207779313704 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVandel, P | |
245 | 0 | 0 |
_aPharmacogenetics and drug therapy in psychiatry--the role of the CYP2D6 polymorphism. _h[electronic resource] |
260 |
_bCurrent pharmaceutical design _c2007 |
||
300 |
_a241-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCytochrome P-450 CYP2D6 _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMental Disorders _xdrug therapy |
650 | 0 | 4 |
_aPharmacogenetics _xmethods |
650 | 0 | 4 |
_aPolymorphism, Genetic _xgenetics |
650 | 0 | 4 |
_aPsychiatry _xmethods |
700 | 1 | _aTalon, J M | |
700 | 1 | _aHaffen, E | |
700 | 1 | _aSechter, D | |
773 | 0 |
_tCurrent pharmaceutical design _gvol. 13 _gno. 2 _gp. 241-50 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/138161207779313704 _zAvailable from publisher's website |
999 |
_c16830876 _d16830876 |